The ArgHe helium token is very innovative so little if anything to compare it to. One positive imo is any funds raised with the token should mean less dilution and debt a win win for all Renergen shareholders.
Cryo-vacc let's see how the 300-500 units planned this year go. Alan Kohler's Eureka Report is one of the few places that clearly details it's potential to match Phase 2 revenues in 3-5 years but unfortunately that article isn't easily accessible. To me it's an x-factor but imagine for every 15000 units in the field being equivalent to potentially about US$300m/yr in revenue. It could be bigger than Phase 2 but for now lets see how it progresses still early days.
Do the math on off-takes for 65% of Phase 2 helium over 10 years.
If you assume 45% of US$321m/yr are helium sales that's US$144m/yr. Then 65% of that is US$94m/yr or US$940m over ten years. This is helium offtakes alone which could potentially be enough to get debt funding to cover a big proportion of the US$800m needed for Phase 2.
RLT Price at posting:
$3.44 Sentiment: Buy Disclosure: Held
